Second-generation antipsychotics and VTE risk

Eur J Haematol. 2024 Aug;113(2):257-259. doi: 10.1111/ejh.14203. Epub 2024 Apr 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Antipsychotic Agents* / therapeutic use
  • Female
  • Humans
  • Male
  • Risk Factors
  • Venous Thromboembolism* / chemically induced
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / etiology

Substances

  • Antipsychotic Agents